The future of the global Contrast Enhanced Digital Mammography Market looks promising with opportunities in the screening and diagnosis markets. The global contrast enhanced digital mammography market is expected to reach an estimated $0.8 billion by 2030 with a CAGR of 10.6% from 2024 to 2030. The major drivers for this market are rising cases of breast cancer, increasing awareness about breast cancer, and introduction of software in mammography equipment.
Some of the key questions
answered in this exclusive report are:
Q.1. What are some of
the most promising, high-growth opportunities for the contrast enhanced digital
mammography market by technique (temporal subtraction and dual energy CEDM),
application (screening and diagnosis), end use (hospital, diagnostic centers,
specialty clinics, and others), and region (North America, Europe, Asia
Pacific, and the Rest of the World)?
Q.2. Which segments will
grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and
why?
Q.4. What are the key
factors affecting market dynamics? What are the key challenges and business
risks in this market?
Q.5. What are the
business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market
and the reasons behind them?
Q.7. What are some of
the changing demands of customers in the market?
Q.8. What are the new
developments in the market? Which companies are leading these developments?
Q.9. Who are the major
players in this market? What strategic initiatives are key players pursuing for
business growth?
Q.10. What are some of
the competing products in this market and how big of a threat do they pose for
loss of market share by material or product substitution?
Q.11. What M&A
activity has occurred in the last 5 years and what has its impact been on the
industry?
Market Segmentation:
In this market, temporal
subtraction and dual energy CEDM are the major segments of contrast enhanced
digital mammography market by technique. Lucintel forecasts that dual energy
CEDM will remain the largest segment over the forecast period as it helps in
detecting the early stage of breast cancer. Within this market, diagnosis will
remain the larger segment because it is used to evaluate the abnormalities
detected during the process of screening in the area of concern.
North America will
remain the largest region over the forecast period due to high prevalence of breast cancer and wide base of medical
device companies in the U.S.
GE Healthcare, Siemens
Healthineers, Allengers Medical Systems, Planmed OY, and Hologic are the major
suppliers in the contrast enhanced digital mammography market.
About
Lucintel
Lucintel, the premier global
management consulting and market research firm, creates winning strategies for
growth. It offers market assessments, competitive analysis, opportunity
analysis, growth
consulting, M&A, and due diligence services to executives and
key decision-makers in a variety of industries.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056
Related Reports
1. Pharmaceutical Contract Manufacturing Market
3. Stent Market
5. 3D Printing Medical
Device Market
8. Medical Lifting Sling
Market
9. Liquid Biopsy Market:
10. Stretcher Market
No comments:
Post a Comment